CoChat

Cross-talk between Peroxisome Proliferator-Activated Receptor δ and Cytosolic Phospholipase A2α/Cyclooxygenase-2/Prostaglandin E2 Signaling Pathways in Human Hepatocellular Carcinoma Cells

Xu, Lihong, Han, Chang, Lim, Kyu, Wu, Tong · 2006 · Cancer Research
Cited by 80

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Peroxisome proliferator-activated receptor δ (PPARδ) is a nuclear transcription factor that is recently implicated in tumorigenesis besides lipid metabolism. This study describes the cross-talk between the PPARδ and prostaglandin (PG) signaling pathways that coordinately regulate human hepatocellular carcinoma (HCC) cell growth. Activation of PPARδ by its pharmacologic ligand, GW501516, enhanced the growth of three human HCC cell lines (HuH7, HepG2, and Hep3B), whereas inhibition of PPARδ by small interfering RNA prevented growth. PPARδ activation up-regulates the expression of cyclooxygenase (COX)-2, a rate-limiting enzyme for PG synthesis, and tumor growth. PPARδ activation or PGE2 treatment also induced the phosphorylation of cytosolic phospholipase A2α (cPLA2α), a key enzyme that releases arachidonic acid substrate for PG production via COX. Activation of cPLA2α by the calcium ionophore A23187 enhanced PPARδ binding to PPARδ response element (DRE) and increased PPARδ reporter activity, which was blocked by the selective cPLA2α inhibitors. Consistent with this, addition of arachidonic acid to isolated nuclear extracts enhanced the binding of PPARδ to DRE in vitro, suggesting a direct role of arachidonic acid for PPARδ activation in the nucleus. Thus, PPARδ induces COX-2 expression and the COX-2–derived PGE2 further activates PPARδ via cPLA2α. Such an interaction forms a novel feed-forward growth-promoting signaling that may play a role in hepatocarcinogenesis. (Cancer Res 2006; 66(24): 11859-68)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-06-1445

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 80

Metadata

Authors
Xu, L., Han, C., Lim, K., & Wu, T.
Venue
Cancer Research
Published
2006-12-15
Volume
66
Issue
24
Pages
11859-11868
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2116679751
Cited by
80
References
7
FWCI
2.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cross-talk between Peroxisome Proliferator-Activated Receptor δ and Cytosolic Phospholipase A2α/Cyclooxygenase-2/Prostaglandin E2 Signaling Pathways in Human Hepatocellular Carcinoma Cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-1445
The paper
Xu, L., Han, C., Lim, K., & Wu, T. (2006). Cross-talk between Peroxisome Proliferator-Activated Receptor δ and Cytosolic Phospholipase A2α/Cyclooxygenase-2/Prostaglandin E2 Signaling Pathways in Human Hepatocellular Carcinoma Cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-1445

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.